Non-adherence with drug treatment after heart or lung transplantation in adults: A systematic review

Patient Education and Counseling

Volumn 81, Issue 2, 2010, Pages 148-154

  Korb Savoldelli, V ^a,b   Sabatier, B ^a,b   Gillaizeau, F ^a,c   Guillemain, R ^a   Prognon, P ^a,d   Begue D ^a   Durieux, P ^a,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Heart transplantation; Lung transplantation; Medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACUTE GRAFT REJECTION; ADJUVANT THERAPY; ADULT; CAREGIVER; COMPUTER SYSTEM; DOCTOR PATIENT RELATION; DRUG MONITORING; DRUG SAFETY; DRUG USE; EVENT FREE SURVIVAL; FEMALE; GRAFT RECIPIENT; HEALTH BELIEF; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; LUNG TRANSPLANTATION; MALE; MICROPROCESSOR; MORTALITY; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PATIENT INTERVIEW; PRIORITY JOURNAL; QUESTIONNAIRE; SELF ADMINISTERED QUESTIONNAIRE; SELF CONCEPT; SELF REPORT; SHORT SURVEY; SYSTEMATIC REVIEW;

ADULT; ANTI-INFECTIVE AGENTS; ATTITUDE TO HEALTH; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MEDICATION ADHERENCE; UNITED STATES;

EID: 77957269899     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2010.04.013     Document Type: Short Survey

References (42)

1. Swanson M.A., Palmeri D., Vossler E.D., Bartus S.A., Hull D., Schweizer R.T. Noncompliance in organ transplant recipients. Pharmacotherapy 1991, 11:173S-174S.
2. Fine R.N., Becker Y., De Geest S., Eisen H., Ettenger R., Evans R., et al. Nonadherence consensus conference summary report. Am J Transplant 2009, 9:35-41. [Review].
3. Cramer J.A., Roy A., Burrell A., Fairchild C.J., Fuldeore M.J., Ollendorf D.A., et al. Medication compliance and persistence: terminology and definitions. Value Health 2008, 11:44-47.
4. Marinker M., Blenkinsopp A., Bond C. From compliance to concordance: achieving shared goals in medicine taking 1997, Royal Pharmaceutical Society of Great Britain, London.
5. Weinman J, Horne R. Concodance, adherence and compliance in medicine taking. Report for the National Co-ordinating Center for NHS Service Delivery and Organisation R and D; December 2005.
6. Veimere E., Hearnshaw H., Van Royen P., Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001, 26:331-342.
7. World Health Organization Adherence to long-term therapies. Evidence for action 2003, World Health Organization, Switzerland.
8. Jay S., Litt I.F., Durant R.H. Compliance with therapeutic regimens. J Adolesc Health Care 1984, 5:124-136.
9. Varni J., Wallander J. Adherence to health-related regimens in pediatric chronic disorders. Clin Psychol Rev 1984, 4:585-596.
10. Kazis L.E., Friedman R.H. Improving medication compliance in the elderly. Strategies for the health care provider. J Am Geriatr Soc 1988, 36:1161-1162.
11. De Geest S., Dobbels F., Fluri C., Paris W., Troosters T. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 2005, 20:588-598.
12. Cherubini P, Rumiati R., Bigoni M., Tursi V., Livi U. Long-term decrease in subjective perceived efficacy of immunosuppressive treatment after heart transplantation. J Heart Lung Transplant 2003, 22:1376-1380.
13. Dobbels F., De Geest S., Van Cleemput J., Droogne W., Vanhaecke J. Effect of late medication non-adherence on outcome after heart transplantation: a 5-year follow-up. J Heart Lung Transplant 2004, 23:1245-1251.
14. De Geest S., Abraham I., Moons P., Vandeputte M., Van Cleemput J., Evers G., et al. Late acute rejection and subclinical nonadherence with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998, 17:854-863.
15. Dew M.A., DiMartini A.F., De Vito Dabbs A. Adherence to the medical regimen during the first two years after lung transplantation. Transplantation 2008, 85:193-202.
16. Dew M.A., Roth L.H., Thompson M.E., Kormos R.L., Griffith B.P. Medical adherence and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996, 15:631-645.
17. Grady K.L., Jalowiec A., White-Williams C. Patient adherence at one year and two years after heart transplantation. J Heart Lung Transplant 1998, 17:383-394.
18. Kugler C., Fischer S., Gottlieb J., Tegtbur U., Welte T., Goerler H., et al. Symptom experience after lung transplantation: impact on quality of life and adherence. Clin Transplant 2007, 21:590-596.
19. Lough M.E., Lindsey A.M., Shinn J.A., Stotts N.A. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart Lung 1987, 16:193.
20. Simmons R.G., Abress L., Anderson C.R. Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation 1998, 45:415.
21. Butler J.A., Roderick P., Mulee M., Mason J.C., Peveler R.C. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004, 77:769-776.
22. Drent G., De Geest S., Dobbels F., Kleibeuker J.H., Haagsma E.B. Symptom experience, nonadherence and quality of life in adult liver transplant recipients. Neth J Med 2009, 67:161-168.
23. Vlaminck H., Maes B., Evers G. Prospective study on late consequences of subclinical non-adherence with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004, 4:1509-1513.
24. Michelon T.F., Piovesan F., Pozza R., Castilho C., Bittar A.E., Keitel E., et al. Nonadherence as a cause of renal graft loss. Transplant Proc 2002, 34:2768-2770.
25. Didlake R.H., Dreyfus K., Kerman R.H., Van Buren C.T., Kahan B.D. Patient nonadherence: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988, 20(Suppl. 3):63-69.
26. Osterberg L., Blaschke T. Adherence to medication. New Engl J Med 2005, 353:487-497.
27. Greenstein S., Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998, 66:1718-1726.
28. Raiz L.R., Kilty K.M., Henry M.L., Ferguson R.M. Medication compliance following renal transplantation. Transplantation 1999, 68:51-55.
29. Ross F.M. Patient compliance-whose responsibility?. Soc Sci Med 1991, 32:89-94.
30. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999, 21:1074-1090. [discussion 1073].
31. Dunbar-Jacob J., Bohachick P., Mortimer M.K., Sereika S.M., Foley S.M. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs 2003, 18:209-218.
32. De Geest S., Borgermans L., Gemoets H., Abraham I., Vlaminck H., Evers G., et al. Incidence, determinants, and consequences of subclinical nonadherence with immunosuppressive therapy in renal transplant recipients. Transplantation 1995, 59:340-347.
33. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007, 26:769-781.
34. Rianthavorn P., Ettenger R.B. Medication non-adherence in the adolescent renal transpalnt recipient: a clinicians viewpoint. Pediatr Transplant 2005, 9:398-407.
35. Berquist R.K., Berquist W.E., Esquivel C.O., Cox K.L., Wayman K.I., Litt I.F. Adolescent non-adherence: prevalence and consequences in liver transplant recipients. Pediatr Transplant 2006, 10:304-310.
36. Weiss L. Mucoviscidose, observance et thérapeutiques. Arch Pédiatr 2003, 10:406s-412s.
37. Jacquin P., Levine M. Poor adherence in chronic conditions during adolescence: understand in order to act. Arch Pédiatr 2008, 15:89-94.
38. Lanuza D.M., McCabe M., Norton-Rosko M., Corliss J.W., Garrity E. Symptom experiences of lung transplant recipients: comparisons across gender, pretransplantation diagnosis, and type of transplantation. Heart Lung 1999, 28:429-437.
39. Hathaway D., Winsett R., Prendergast M., Subaiya I. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clin Transplant 2003, 17:183-194.
40. Pound P., Britten N., Morgan M., Yardley L., Pope C., Daker-White G., et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005, 61:133-155.
41. Donovan J.L. Patient decision making: the missing ingredient in compliance research. Int J Technol Assess Health Care 1995, 11:443-455.
42. Dew M.A., DiMartini A.F., De Vito Dabbs A., Myaskovsky L., Steel J., Unruh M., et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007, 83:858-873.